Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$3.0400
+0.0600 (2.0134%)
- Prev. close
- 2.9800
- Volume
- 150,238
- High
- 3.0900
- Capitalization
- 138.855M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€2.6560
-0.0500 (-1.8477%)
- Prev. close
- 2.7060
- Volume
- 138,792
- High
- 2.7020
- Capitalization
- 190.126M
Covering research analysts
Barclays - Gena Wang
Bryan Garnier - Alex Cogut
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter
Jefferies - Kelly Shi
JMP Securities - Silvan Tuerkcan
Jones Trading - Soumit Roy
Kempen - Sebastiaan van der Schoot
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
RW Baird - Jack Allen
Wells Fargo – Yanan Zhu
Cellectis contact information
Arthur Stril, Chief Business Officer
Ashley R. Robinson, LifeSci Advisors
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89